Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing
Black Friday Get Elite for just $149.00 Claim Now
Market News Market Pulse Stocks News ETF News Crypto News

ADMA Biologics, Inc.

Contributing Author

Recent Articles by ADMA Biologics, Inc.

Nov-04
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update ADMA -5.67% ADMA +26.05% GlobeNewswire
Oct-28
ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026 ADMA GlobeNewswire
Oct-15
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process ADMA GlobeNewswire
Aug-05
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update ADMA ADMA +8.64% GlobeNewswire
Jul-29
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026 ADMA GlobeNewswire
May-06
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update ADMA ADMA -15.97% GlobeNewswire
May-04
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV to Include Pediatric Immune Compromised Patients Two Years of Age and Older ADMA GlobeNewswire
Apr-29
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026 ADMA GlobeNewswire
Mar-27
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research ADMA +11.58% GlobeNewswire
Mar-25
ADMA Biologics Addresses Misleading Short-Seller Report ADMA -15.00% GlobeNewswire
Mar-02
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative ADMA +6.49% GlobeNewswire
Feb-25
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update ADMA GlobeNewswire
Feb-18
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 ADMA GlobeNewswire
Jan-12
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update ADMA GlobeNewswire
Jan-05
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 ADMA GlobeNewswire
Nov-05
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update ADMA +5.06% ADMA -8.72% GlobeNewswire
Oct-29
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 ADMA GlobeNewswire
Aug-06
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update ADMA ADMA -9.65% GlobeNewswire
Jul-30
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 ADMA GlobeNewswire
May-07
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update ADMA ADMA -10.21% GlobeNewswire
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)